BMO Capital analyst Michael Zaremski initiated coverage of Horace Mann with an Outperform rating and $48 price target. The company's captive-focused distribution differs from the majority of peer insurers who rely on 3rd party independent sales agents, the analyst tells investors in a research note. BMO adds that Horace Mann's strategy of selling mainly to schoolteachers via its captive salesforce is one that can bear meaningful fruit, so long as it executes on its current revamped sales strategy.
